Pharmaceutical Contract Manufacturing Organization
Renaissance develops and manufactures high-quality pharmaceuticals to fulfill your patients’ needs.
Your Partner for Nasal Sprays
State-of-the-art laboratory
Cutting edge spray characterization instruments, almost 20 years in nasal experience, and successful commercialization of products for the US and global markets, Renaissance is the “one-stop-shop” for all your nasal spray formulation, development, testing, and commercialization needs.
LEARN MORETrusted, Reliable Contract Manufacturing
World-class sterile liquid manufacturing
Renaissance is a global, pure-play contract development and manufacturing organization (“CDMO”) leader with an unparalleled bench-to-shelf service offering for nasal and sterile injectable dosage forms.
LEARN MORE1979
Where it all started. Paco Packaging & Labs relocates to Paco Way in Lakewood, NJ from Philadelphia, PA.
LEARN MORENews & Events
September 30, 2024
Renaissance Lakewood, LLC Supports ARS Pharmaceuticals, Inc.’s Launch of World’s First Nasal Spray for Life-Threatening Allergies
Renaissance Lakewood, LLC (“Renaissance”), a leading global contract development and manufacturing organization (“CDMO”) is proud to be manufacturing neffy®, which is now commercially available in the US.
READ MORESeptember 3, 2024
RENAISSANCE LAKEWOOD, LLC ANNOUNCES COMPLETION OF CAMPUS ENHANCEMENT PROJECT
Renaissance Lakewood, LLC (“Renaissance”), a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ.
READ MOREAugust 28, 2024
DDL 2024 – Drug Delivery to the Lungs Conference
Premier International Pulmonary & Nasal Drug Delivery Conference at The Edinburgh International Conference Centre – The Exchange in Edinburgh, Scotland, December 11 – December 13, 2024
READ MORE+$30m
+$30 million in facilities and equipment investments since 2020
1st
Manufacturer of the first FDA approved bi-dose nasal spray drug
310k
Sq. ft. of infrastructure with additional space under construction
+10
cGMP manufacturing suites with additional under construction